A phase I clinical trial of an anti-CD25-deglycosylated ricin a-chain immunotoxin (RFT5-SMPT-DGA) in patients with Hodgkin’s lymphoma restistent to conventional therapy

✍ Scribed by R. Schnell; A. Radszuhn; M. -T. Hatwig; F. Cebe; S. Poyraz; S. Drillich; G. Schön; H. Bohlen; O. Manske; H. Tesch; M. -L. Hansmann; J. Schindler; V. Ghetie; J. Uhr; E. S. Vitetta; V. Diehl; A. Engert

• Book ID: 112784716
• Publisher: Springer-Verlag
• Year: 1995
• Tongue: English
• Weight: 152 KB
• Volume: 121
• Category: Article
• ISSN: 1432-1335
• DOI: 10.1007/bf02572173